# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001367644-23-000207
Filing Date
2023-12-11
Accepted
2023-12-11 07:17:14
Documents
133
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | ebs-20221231.htm iXBRL | 10-K/A | 3286138
2 | EX-23 | a23-eyxemergentconsent10xk.htm | EX-23 | 7288
3 | EX-31.1 | a311-millercert12312210xka.htm | EX-31.1 | 8508
4 | EX-31.2 | a312-lindahlcert12312210xka.htm | EX-31.2 | 8572
5 | EX-32.1 | a321-millercert12312210xka.htm | EX-32.1 | 3557
6 | EX-32.2 | a322-lindahlcert12312210xka.htm | EX-32.2 | 3407
12 |  | ebs-20221231_g1.jpg | GRAPHIC | 75656
| Complete submission text file | 0001367644-23-000207.txt |  | 17956596

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20221231.xsd | EX-101.SCH | 82459
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ebs-20221231_cal.xml | EX-101.CAL | 131635
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20221231_def.xml | EX-101.DEF | 588927
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20221231_lab.xml | EX-101.LAB | 1098398
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20221231_pre.xml | EX-101.PRE | 889985
127 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20221231_htm.xml | XML | 3677741

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33137 | Film No.: 231476904
SIC: 2834 Pharmaceutical Preparations